Insight into the pathophysiology of an enigmatic and debilitating disease suggests new treatment approaches.

A new method speeds the analysis of factors that control gene expression from days to minutes, allowing researchers to uncover new targets for cancer treatment.

A rare tumor that causes facial weakness was found masquerading as a more common benign facial tumor.

A blood stem cell protein plays a role in the initiation and progression of leukemia, Vanderbilt researchers have found.

Brain inflammation links genetic and acquired epilepsy — providing new clues about epilepsy development and pointing to potential treatments.

William Tansey and colleagues identified proteins that interact with the cancer drug target WDR5 and are important for cancer cell growth.

Oxidative stress and toxic products called isolevuglandins in mitochondria play a role in endothelial dysfunction and hypertension — and getting rid of them with a special “scavenger” molecule has therapeutic potential.